Psychometric Properties of the Polish version of the Drug-Use Disorders Identification Test.


Journal

European addiction research
ISSN: 1421-9891
Titre abrégé: Eur Addict Res
Pays: Switzerland
ID NLM: 9502920

Informations de publication

Date de publication:
2020
Historique:
received: 11 12 2018
accepted: 24 01 2020
pubmed: 18 2 2020
medline: 21 10 2020
entrez: 17 2 2020
Statut: ppublish

Résumé

Substance use is a growing problem worldwide, and there is a great need to develop national policies addressing prevention and treatment of substance-use disorders (SUD). However, the lack of a commonly used, valuable diagnostic tool to assess the symptoms of SUDs precludes comparison of the prevalence of drug-use problems as well as the efficacy of policy strategies applied in different countries. This study was conducted to validate one of the commonly used scales the Drug Use Disorders Identification Test (the DUDIT) for use in Polish condition. The aims of this study were to test the reliability of the DUDIT in the Polish population, to confirm the comparative stability of the factor structure of the instrument, and to verify previously proposed DUDIT cutoff scoring. The group of drug users comprised 127 patients aged 19-40 years (mean age 30.37, SD 6.36) with a diagnosis of SUD, while the control group consisted of 533 students aged 19-25 years (mean age 20.72, SD 1.88). All participants completed the Polish version of the DUDIT. Internal consistency of the Polish version of the DUDIT was determined, and subsequently external validation was performed. Analysis showed that the Polish version of the DUDIT was characterized by a good reliability based on Cronbach's α, with a value of 0.92. The between-group comparison revealed a significant difference between the control group and substance-dependent patients corresponding to a large effect size (Cohen's d = 3.27). The receiver-operating characteristic analysis, comparing the DUDIT score to the ICD-10 diagnosis of SUD, showed an optimal cutoff value of 7 points, with a sensitivity of 0.929 and a specificity of 0.974. These results constitute preliminary evidence that the Polish version of the DUDIT may be a valid and reliable screening tool for drug-use disorders in the Polish population.

Sections du résumé

BACKGROUND BACKGROUND
Substance use is a growing problem worldwide, and there is a great need to develop national policies addressing prevention and treatment of substance-use disorders (SUD). However, the lack of a commonly used, valuable diagnostic tool to assess the symptoms of SUDs precludes comparison of the prevalence of drug-use problems as well as the efficacy of policy strategies applied in different countries. This study was conducted to validate one of the commonly used scales the Drug Use Disorders Identification Test (the DUDIT) for use in Polish condition.
OBJECTIVES OBJECTIVE
The aims of this study were to test the reliability of the DUDIT in the Polish population, to confirm the comparative stability of the factor structure of the instrument, and to verify previously proposed DUDIT cutoff scoring.
METHODS METHODS
The group of drug users comprised 127 patients aged 19-40 years (mean age 30.37, SD 6.36) with a diagnosis of SUD, while the control group consisted of 533 students aged 19-25 years (mean age 20.72, SD 1.88). All participants completed the Polish version of the DUDIT. Internal consistency of the Polish version of the DUDIT was determined, and subsequently external validation was performed.
RESULTS RESULTS
Analysis showed that the Polish version of the DUDIT was characterized by a good reliability based on Cronbach's α, with a value of 0.92. The between-group comparison revealed a significant difference between the control group and substance-dependent patients corresponding to a large effect size (Cohen's d = 3.27). The receiver-operating characteristic analysis, comparing the DUDIT score to the ICD-10 diagnosis of SUD, showed an optimal cutoff value of 7 points, with a sensitivity of 0.929 and a specificity of 0.974.
CONCLUSION CONCLUSIONS
These results constitute preliminary evidence that the Polish version of the DUDIT may be a valid and reliable screening tool for drug-use disorders in the Polish population.

Identifiants

pubmed: 32062646
pii: 000506156
doi: 10.1159/000506156
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

131-140

Informations de copyright

© 2020 S. Karger AG, Basel.

Auteurs

Anna Klimkiewicz (A)

Department of Psychiatry, Medical University of Warsaw, Warsaw, Poland.
Nowowiejski Psychiatric Hospital, Warsaw, Poland.

Andrzej Jakubczyk (A)

Department of Psychiatry, Medical University of Warsaw, Warsaw, Poland.
Nowowiejski Psychiatric Hospital, Warsaw, Poland.

Anna Mach (A)

Department of Psychiatry, Medical University of Warsaw, Warsaw, Poland, anna.mach@wum.edu.pl.
Nowowiejski Psychiatric Hospital, Warsaw, Poland, anna.mach@wum.edu.pl.

Małgorzata Abramowska (M)

Department of Psychiatry, Medical University of Warsaw, Warsaw, Poland.

Piotr Serafin (P)

Nowowiejski Psychiatric Hospital, Warsaw, Poland.

Jan Szczypiński (J)

Department of Psychiatry, Medical University of Warsaw, Warsaw, Poland.
Laboratory of Brain Imaging, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.

Marta Demkow (M)

Nowowiejski Psychiatric Hospital, Warsaw, Poland.

Marcin Wojnar (M)

Department of Psychiatry, Medical University of Warsaw, Warsaw, Poland.
Nowowiejski Psychiatric Hospital, Warsaw, Poland.
Department of Psychiatry, University of Michigan, Ann Arbor, Michigan, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH